That vaccine is designed to target the XBB.1.5 Omicron subvariant. According to CDC data, it appears to protect against JN.1, ...

According to data from the Centers for Disease Control and Prevention (CDC), Omicron JN.1 became the dominant COVID strain in the U.S. last December ... are designed to target the XBB.1.5 Omicron ...

In September, the government recommended a new COVID-19 shot recipe built against a version of the coronavirus called XBB.1.5 ...

Here’s your go-to guide with everything you need to know about COVID-19, including testing expanding to more airports, ...

The vaccine provided similar levels of protection against XBB lineage variants ... risk for severe disease from COVID. In a ...

according to CDC data. Vaccine effectiveness against hospitalization was 38% in the first 7 to 59 days after receipt of the updated monovalent XBB.1.5 COVID vaccine, and 34% in the 60 to 119 days ...

The CDC noted that COVID-19 has seen similar peaks and valleys ... which was formulated to target the XBB.1.5 subvariant. The ...

The U.S. Centers for Disease Control and Prevention (CDC) has released new data addressing the link, or lack thereof, between the COVID-19 vaccine and sudden cardiac death in otherwise healthy ...

Independent reviewers confirmed a causal relationship between the first mRNA COVID-19 vaccines and myocarditis, and also ...

A Centers for Disease Control and Prevention (CDC) study has found that mRNA vaccines for the COVID-19 virus are not linked to cardiac death in younger adults. The study was conducted using Oregon ...

The vaccines were changed to target a strain of the virus that causes COVID-19 called XBB.1.5. In September and October 2023 ... System in the U.S. This data is available to the public. The CDC also ...

27% either tested positive for COVID or reported COVID-like symptoms. At the time of the conference, the CDC did not require attendees to wear masks. The study authors said high levels of ...